Relations of Circulating Resistin and Adiponectin and Cardiac Structure and Function: the Framingham Offspring Study

Overview

Journal Obesity (Silver Spring)

Specialties Endocrinology
Nutritional Sciences
Physiology

Date 2011 Feb 26

PMID 21350435

Citations 37

Authors

David D McManus

Asya Lyass

Erik Ingelsson

Joseph M Massaro

James B Meigs

Jayashri Aragam

Emelia J Benjamin

Ramachandran S Vasan

Affiliations

Soon will be listed here.

Abstract

Obesity is associated with pathological cardiac remodeling and risk of heart failure (HF). Adipocytokines (ADKs) may mediate the increased risk of cardiovascular disease associated with excess adiposity. Yet data relating ADKs to cardiac remodeling phenotypes are sparse. We related two circulating ADKs, resistin and adiponectin, to three important echocardiographic markers of cardiac remodeling, left ventricular mass (LVM), left atrial diameter (LAD), and LV fractional shortening (LVFS) in 2,615 participants (mean age 61 years, 55% women) in the Framingham Offspring Study. Adiponectin concentrations were inversely related to LVM in multivariable linear regression models adjusting for key clinical correlates including BMI (regression coefficient per s.d.-increment in ln-adiponectin = -3.37, P = 0.02; P for trend across quartiles = 0.02). Adiponectin was not associated with LAD or LVFS (P > 0.56). Resistin concentrations were inversely related to LVFS (regression coefficient per s.d.-increment in ln-resistin = -0.01, P = 0.03; P for trend across quartiles = 0.04). Resistin was not associated with LVM or LAD (P > 0.05). In our moderate-sized, community-based sample, higher circulating concentrations of adiponectin and resistin were associated with lower LVM and lower LVFS, respectively. In conclusion, these associations identify potential mechanisms by which excess adiposity may mediate adverse cardiac remodeling and HF risk.

Citing Articles

Cardiac-to-adipose axis in metabolic homeostasis and diseases: special instructions from the heart.

Tang S, Li R, Ma W, Lian L, Gao J, Cao Y Cell Biosci. 2023; 13(1):161.

PMID: 37667400 PMC: 10476430. DOI: 10.1186/s13578-023-01097-1.

Adiponectin and metabolic cardiovascular diseases: Therapeutic opportunities and challenges.

Lei X, Qiu S, Yang G, Wu Q Genes Dis. 2023; 10(4):1525-1536.

PMID: 37397515 PMC: 10311114. DOI: 10.1016/j.gendis.2022.10.018.

The role of obesity-related cardiovascular remodelling in mediating incident cardiovascular outcomes: a population-based observational study.

Szabo L, McCracken C, Cooper J, Rider O, Vago H, Merkely B Eur Heart J Cardiovasc Imaging. 2023; 24(7):921-929.

PMID: 36660920 PMC: 10284050. DOI: 10.1093/ehjci/jeac270.

Environmental Contaminants Acting as Endocrine Disruptors Modulate Atherogenic Processes: New Risk Factors for Cardiovascular Diseases in Women?.

Migliaccio S, Bimonte V, Besharat Z, Sabato C, Lenzi A, Crescioli C Biomolecules. 2022; 12(1).

PMID: 35053192 PMC: 8773563. DOI: 10.3390/biom12010044.

Abnormal transaminase and lipid profiles in coexisting diseases in patients with fatty liver: a population study in Sichuan.

Jiang W, Liu C, Wu D, Wang Y, Tang H Biosci Rep. 2021; 41(12).

PMID: 34918746 PMC: 8685641. DOI: 10.1042/BSR20211769.

References

Pritchett A, Mahoney D, Jacobsen S, Rodeheffer R, Karon B, Redfield M . Diastolic dysfunction and left atrial volume: a population-based study. J Am Coll Cardiol. 2005; 45(1):87-92. DOI: 10.1016/j.jacc.2004.09.054. View

Vasan R, Sullivan L, Roubenoff R, Dinarello C, Harris T, Benjamin E . Inflammatory markers and risk of heart failure in elderly subjects without prior myocardial infarction: the Framingham Heart Study. Circulation. 2003; 107(11):1486-91. DOI: 10.1161/01.cir.0000057810.48709.f6. View

Ogawa R, Tanaka C, Sato M, Nagasaki H, Sugimura K, Okumura K . Adipocyte-derived microvesicles contain RNA that is transported into macrophages and might be secreted into blood circulation. Biochem Biophys Res Commun. 2010; 398(4):723-9. DOI: 10.1016/j.bbrc.2010.07.008. View

Roubicek T, Bartlova M, Krajickova J, Haluzikova D, Mraz M, Lacinova Z . Increased production of proinflammatory cytokines in adipose tissue of patients with end-stage renal disease. Nutrition. 2009; 25(7-8):762-8. DOI: 10.1016/j.nut.2008.12.012. View

Wade M, Chandraratna P, Reid C, Lin S, Rahimtoola S . Accuracy of nondirected and directed M-mode echocardiography as an estimate of left atrial size. Am J Cardiol. 1987; 60(14):1208-11. DOI: 10.1016/0002-9149(87)90434-6. View

Ohmori R, Momiyama Y, Kato R, Taniguchi H, Ogura M, Ayaori M . Associations between serum resistin levels and insulin resistance, inflammation, and coronary artery disease. J Am Coll Cardiol. 2005; 46(2):379-80. DOI: 10.1016/j.jacc.2005.04.022. View

Keaney Jr J, Larson M, Vasan R, Wilson P, Lipinska I, Corey D . Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol. 2003; 23(3):434-9. DOI: 10.1161/01.ATV.0000058402.34138.11. View

. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 2002; 26 Suppl 1:S5-20. DOI: 10.2337/diacare.26.2007.s5. View

Ebinc H, Ayerden Ebinc F, Ozkurt Z, Dogru M, Tulmac M, Yilmaz M . Impact of adiponectin on left ventricular mass index in non-complicated obese subjects. Endocr J. 2008; 55(3):523-8. DOI: 10.1507/endocrj.k07e-098. View

10.

Kenchaiah S, Evans J, Levy D, Wilson P, Benjamin E, Larson M . Obesity and the risk of heart failure. N Engl J Med. 2002; 347(5):305-13. DOI: 10.1056/NEJMoa020245. View

11.

Biolo A, Shibata R, Ouchi N, Kihara S, Sonoda M, Walsh K . Determinants of adiponectin levels in patients with chronic systolic heart failure. Am J Cardiol. 2010; 105(8):1147-52. PMC: 2854672. DOI: 10.1016/j.amjcard.2009.12.015. View

12.

Imai J, Katagiri H, Yamada T, Ishigaki Y, Ogihara T, Uno K . Cold exposure suppresses serum adiponectin levels through sympathetic nerve activation in mice. Obesity (Silver Spring). 2006; 14(7):1132-41. DOI: 10.1038/oby.2006.130. View

13.

Shibata R, Ouchi N, Ito M, Kihara S, Shiojima I, Pimentel D . Adiponectin-mediated modulation of hypertrophic signals in the heart. Nat Med. 2004; 10(12):1384-9. PMC: 2828675. DOI: 10.1038/nm1137. View

14.

Devereux R, Alonso D, Lutas E, Gottlieb G, Campo E, Sachs I . Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol. 1986; 57(6):450-8. DOI: 10.1016/0002-9149(86)90771-x. View

15.

Steppan C, Bailey S, Bhat S, Brown E, Banerjee R, Wright C . The hormone resistin links obesity to diabetes. Nature. 2001; 409(6818):307-12. DOI: 10.1038/35053000. View

16.

Knutsen K, Stugaard M, Michelsen S, Otterstad J . M-mode echocardiographic findings in apparently healthy, non-athletic Norwegians aged 20-70 years. Influence of age, sex and body surface area. J Intern Med. 1989; 225(2):111-5. DOI: 10.1111/j.1365-2796.1989.tb00049.x. View

17.

Kozakova M, Muscelli E, Flyvbjerg A, Frystyk J, Morizzo C, Palombo C . Adiponectin and left ventricular structure and function in healthy adults. J Clin Endocrinol Metab. 2008; 93(7):2811-8. DOI: 10.1210/jc.2007-2580. View

18.

Kannel W, Feinleib M, MCNAMARA P, Garrison R, CASTELLI W . An investigation of coronary heart disease in families. The Framingham offspring study. Am J Epidemiol. 1979; 110(3):281-90. DOI: 10.1093/oxfordjournals.aje.a112813. View

19.

Pischon T, Girman C, Hotamisligil G, Rifai N, Hu F, Rimm E . Plasma adiponectin levels and risk of myocardial infarction in men. JAMA. 2004; 291(14):1730-7. DOI: 10.1001/jama.291.14.1730. View

20.

Shetty G, Economides P, Horton E, Mantzoros C, Veves A . Circulating adiponectin and resistin levels in relation to metabolic factors, inflammatory markers, and vascular reactivity in diabetic patients and subjects at risk for diabetes. Diabetes Care. 2004; 27(10):2450-7. DOI: 10.2337/diacare.27.10.2450. View